Laboratorio Reig Jofre SA is a company that prioritizes values and embraces a strong corporate philosophy. With a focus on integrity, innovation, and excellence, Laboratorio Reig Jofre SA aims to bring pharmaceutical solutions that improve patients' lives. They are committed to conducting business ethically and responsibly, ensuring the highest standards of quality and safety in all their products. Laboratorio Reig Jofre SA emphasizes continuous research and development, collaborating with healthcare professionals and strategic partners to deliver cutting-edge pharmaceutical solutions. This dedication to values and a robust corporate philosophy has established Laboratorio Reig Jofre SA as a trusted and respected player in the pharmaceutical industry.

Laboratorio Reig Jofre SA is primarily present in Spain, where it is headquartered.

Laboratorio Reig Jofre SA, a renowned pharmaceutical company, has achieved several significant milestones throughout its history. Notably, the company has made remarkable strides in research and development, leading to the successful launch of numerous innovative drugs and vaccines. Laboratorio Reig Jofre SA has also expanded its global presence through strategic partnerships and acquisitions, positioning itself as a key player in the international pharmaceutical industry. The company's commitment to quality and patient well-being has garnered recognition, with various certifications and awards honoring its excellence. These achievements highlight Laboratorio Reig Jofre SA's dedication to improving healthcare and its continuous pursuit of innovation in the pharmaceutical sector.

Laboratorio Reig Jofre SA is a renowned pharmaceutical company with a rich history and strong background. Established in Spain, the company has been providing innovative healthcare solutions since its inception. With expertise in research, development, and manufacturing, Laboratorio Reig Jofre SA has become a leading player in the pharmaceutical industry. Its commitment to quality, safety, and efficacy has earned it a solid reputation worldwide. Over the years, the company has expanded its product portfolio, offering a wide range of medicines and healthcare products that cater to diverse medical needs. Laboratorio Reig Jofre SA's consistent growth and dedication to advancing healthcare make it an influential and trusted player in the industry.

The main competitors of Laboratorio Reig Jofre SA in the market include pharmaceutical companies such as Laboratorios Farmacéuticos Rovi SA, Almirall SA, and Grifols SA. These companies operate in the same industry and offer similar products and services, competing for market share and customers. With its strong presence and reputation, Laboratorio Reig Jofre SA faces tough competition from these key players in the pharmaceutical market.

Laboratorio Reig Jofre SA is primarily active in the pharmaceutical industry.

Laboratorio Reig Jofre SA is a pharmaceutical company based in Spain. Their business model is focused on the research, development, and production of innovative pharmaceutical products. They specialize in the manufacturing of medicines, particularly in the areas of women's health, neurology, and hospital products. Laboratorio Reig Jofre SA aims to improve patients' quality of life by providing them with high-quality, reliable, and affordable medications. They strive to be an industry leader, constantly adapting to market demands and regulatory requirements. With a commitment to innovation and a customer-centric approach, Laboratorio Reig Jofre SA continues to make significant contributions to the pharmaceutical industry.

The Laboratorio Reig Jofre P/E ratio is 16.39.

The Laboratorio Reig Jofre P/S ratio is 0.62.

The Quality Investing for Laboratorio Reig Jofre is 6/10.

The expected Laboratorio Reig Jofre revenue is 350.29 M EUR.

The expected Laboratorio Reig Jofre profit is 13.22 M EUR.

Laboratorio Reig Jofre SA (LRJ) is a pharmaceutical company that specializes in the manufacture of medicinal products, vaccines, and over-the-counter products. The company was founded in 1929 and is headquartered in Barcelona, Spain. LRJ is listed on the Madrid stock exchange and employs approximately 1,000 people worldwide.

Laboratorio Reig Jofre pays a dividend of 1 EUR distributed over payouts per year.

The dividend cannot currently be calculated for Laboratorio Reig Jofre or the company does not pay out a dividend.

The ISIN of Laboratorio Reig Jofre is ES0165359029.

The WKN of Laboratorio Reig Jofre is A140EW.

The ticker of Laboratorio Reig Jofre is RJF.MC.

Over the past 12 months, Laboratorio Reig Jofre paid a dividend of 0.08 EUR . This corresponds to a dividend yield of about 2.91 %. For the coming 12 months, Laboratorio Reig Jofre is expected to pay a dividend of 0.06 EUR.

The current dividend yield of Laboratorio Reig Jofre is 2.91 %.

Laboratorio Reig Jofre pays a quarterly dividend. This is distributed in the months of July, August, June, June.

Laboratorio Reig Jofre paid dividends every year for the past 10 years.

For the upcoming 12 months, dividends amounting to 0.06 EUR are expected. This corresponds to a dividend yield of 2.23 %.

Laboratorio Reig Jofre is assigned to the 'Health' sector.

To receive the latest dividend of Laboratorio Reig Jofre from 6/21/2024 amounting to 0.04 EUR, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.

The last dividend was paid out on 6/21/2024.

In the year 2023, Laboratorio Reig Jofre distributed 0.996 EUR as dividends.

The dividends of Laboratorio Reig Jofre are distributed in EUR.